Literature DB >> 26277931

Study of the True Clinical Progression of Autosomal Dominant Alport Syndrome in a European Population.

Consolación Rosado1, Elena Bueno, Carmen Felipe, Sebastián Valverde, Rogelio González-Sarmiento.   

Abstract

BACKGROUND/AIMS: Autosomal dominant Alport syndrome represents 5% of all Alport syndrome cases. This entity presents a different clinical expression from the recessive inheritance pattern and the X chromosome-linked pattern, because it is mild and it shows a late onset, which in many cases even goes unnoticed.
METHODS: We carried out a descriptive observational and retrospective clinical study on 19 patients from 5 families with a clinical diagnosis of autosomal dominant Alport Syndrome, and we analyzed the expression of the symptoms in the different families, comparing the results with what has been described in the literature.
RESULTS: Renal involvement appeared at a young age, with a progression towards end-stage chronic kidney disease at a median age of 31 years (20.5-36.5). Hearing involvement also appeared in early stages, at a median age of 28.5 years (7.5-62.5). Also, we observed ocular lenticonus-like injuries, which until now have only been described in other inheritance patterns.
CONCLUSIONS: Our results suggest that dominant patterns are accompanied by a severe clinical expression that can be superimposed to the recessive and X chromosome-linked patterns, contrary to what has been classically stated. The high phenotypic variability observed in the families lead to the fact that many cases go unnoticed and the severest cases are erroneously diagnosed as recessive, which means that the real prevalence of dominant forms is probably higher than the current 5%.
© 2015 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26277931     DOI: 10.1159/000368519

Source DB:  PubMed          Journal:  Kidney Blood Press Res        ISSN: 1420-4096            Impact factor:   2.687


  7 in total

Review 1.  Rare genetic causes of complex kidney and urological diseases.

Authors:  Emily E Groopman; Gundula Povysil; David B Goldstein; Ali G Gharavi
Journal:  Nat Rev Nephrol       Date:  2020-08-17       Impact factor: 28.314

Review 2.  Expert consensus guidelines for the genetic diagnosis of Alport syndrome.

Authors:  Judy Savige; Francesca Ariani; Francesca Mari; Mirella Bruttini; Alessandra Renieri; Oliver Gross; Constantinos Deltas; Frances Flinter; Jie Ding; Daniel P Gale; Mato Nagel; Michael Yau; Lev Shagam; Roser Torra; Elisabet Ars; Julia Hoefele; Guido Garosi; Helen Storey
Journal:  Pediatr Nephrol       Date:  2018-07-09       Impact factor: 3.714

Review 3.  Population-based studies reveal an additive role of type IV collagen variants in hematuria and albuminuria.

Authors:  Moumita Barua; Andrew D Paterson
Journal:  Pediatr Nephrol       Date:  2021-02-26       Impact factor: 3.714

4.  Autosomal dominant form of type IV collagen nephropathy exists among patients with hereditary nephritis difficult to diagnose clinicopathologically.

Authors:  Aya Imafuku; Kandai Nozu; Naoki Sawa; Eiko Hasegawa; Rikako Hiramatsu; Masahiro Kawada; Junichi Hoshino; Kiho Tanaka; Yasuo Ishii; Kenmei Takaichi; Takeshi Fujii; Kenichi Ohashi; Kazumoto Iijima; Yoshifumi Ubara
Journal:  Nephrology (Carlton)       Date:  2018-10       Impact factor: 2.506

5.  Prevalence of clinical, pathological and molecular features of glomerular basement membrane nephropathy caused by COL4A3 or COL4A4 mutations: a systematic review.

Authors:  Andreas Matthaiou; Tsielestina Poulli; Constantinos Deltas
Journal:  Clin Kidney J       Date:  2020-02-10

6.  New Insights into Renal Failure in a Cohort of 317 Patients with Autosomal Dominant Forms of Alport Syndrome: Report of Two Novel Heterozygous Mutations in COL4A3.

Authors:  José María García-Aznar; Luis De la Higuera; Lara Besada Cerecedo; Nerea Paz Gandiaga; Ana Isabel Vega; Gema Fernández-Fresnedo; Domingo González-Lamuño
Journal:  J Clin Med       Date:  2022-08-19       Impact factor: 4.964

7.  Should We Diagnose Autosomal Dominant Alport Syndrome When There Is a Pathogenic Heterozygous COL4A3 or COL4A4 Variant?

Authors:  Judy Savige
Journal:  Kidney Int Rep       Date:  2018-08-22
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.